Main navigation

Annual Report Homepage
Foreword
Introduction
CHAPTER 1
Key achievements in 2019
Evaluation and monitoring of medicines: highlights
Relocation to the Netherlands and preparations for Brexit
New EU legislation applicable to EMA
Shortages and availability of medicines
Regulatory science strategy to 2025
A decisive year for big data in medicines regulation: towards data-driven decision-making
Nitrosamine impurities: the network's response
Antimicrobial resistance
2019 - year in brief
CHAPTER 2
Key figures in 2019
Human medicines
Veterinary medicines
Inspections and compliance
Network, stakeholders, administration and communication

2019 - year in brief

Assembly area

Heading

Rich text

Pager